European Union fines biotech giant Illumina $475 million for taking over cancer-screening company Grail without approval
BRUSSELS — European Union fines biotech giant Illumina $475 million for taking over cancer-screening company Grail without approval.
#European #Union #fines #biotech #giant #Illumina #million #cancerscreening #company #Grail #approval